...Openshaw as EVP for corporate development, formerly executive director in the Life Sciences Group at WestLB Panmure...

...Capital. Code will be led by Chief Executive Chris Collins, who formerly was head of WestLB Panmure's...

...the European biotech sector from the firm's London office. He previously covered European biotech for WestLB Panmure...

...a senior equity research analyst covering European biotech companies. Campbell previously covered European biotech for WestLB Panmure...

...Feb. 28, 2003, REN had £5.7 million ($9 million) in cash. REN was advised by WestLB Panmure...

...As of Feb. 28, 2003, REN had L5.7 million in cash. REN was advised by WestLB Panmure...

...dressing device to treat leg ulcers. Nomura will be the joint broker on the deal. WestLB Panmure...

...graft surgery in hemodialysis patients and EG009 in Phase IIb trials to treat malignant glioma. WestLB Panmure...

...blood vessel blockage after vascular graft surgery in hemodialysis patients, and two Phase II compounds. WestLB Panmure...

...BioCentury, Nov. 12, 2001). "The coffers are expected to run dry by year end," said WestLB Panmure...
...£327 million ($463 million). Vaccine play Bavarian Nordic (CSE:BAVA) fell DKK17 (20%) to DKK67 after WestLB Panmure...